Propanc Biopharma (PPCB) Times Interest Earned (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Times Interest Earned of -$61.99 for Q4 2025, down 3355.54% year-over-year from $1.9 in Q4 2024, and down 305.42% quarter-over-quarter from -$15.29 in Q3 2025.
Propanc Biopharma (PPCB) Times Interest Earned (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Times Interest Earned for 15 consecutive years, with -$61.99 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned fell 3355.54% year-over-year to -$61.99; the TTM figure through Dec 2025 stood at -$342.38 (down 12275.98% YoY), while the FY2025 annual figure was -$2.4, down 1692.41% from the prior year.
- Times Interest Earned retreated to -$61.99 in Q4 2025 per PPCB's latest filing, from -$15.29 in the prior quarter.
- Across five years, Times Interest Earned topped out at $13.09 in Q2 2025 and bottomed at -$510.65 in Q1 2025.
- Historically, Times Interest Earned has averaged -$31.14 across 5 years, with a median of -$3.08 in 2022.
- On a YoY basis, Times Interest Earned climbed as much as 553.27% in 2025 and fell as far as 16054.28% in 2025.
- Propanc Biopharma's Times Interest Earned stood at -$2.27 in 2021, then slumped by 171.85% to -$6.17 in 2022, then surged by 73.13% to -$1.66 in 2023, then decreased by 8.3% to -$1.79 in 2024, then plunged by 3355.54% to -$61.99 in 2025.
- Business Quant data shows PPCB's Times Interest Earned at -$61.99 in Q4 2025, -$15.29 in Q3 2025, and $13.09 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | -61.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.99 |
| Sep 30, 2025 | -15.29 |
| Jun 30, 2025 | 13.09 |
| Mar 31, 2025 | -510.65 |
| Dec 31, 2024 | -1.79 |
| Sep 30, 2024 | -3.37 |
| Jun 30, 2024 | -2.89 |
| Mar 31, 2024 | -3.16 |
| Dec 31, 2023 | -1.66 |
| Sep 30, 2023 | -2.34 |
| Jun 30, 2023 | -2.70 |
| Mar 31, 2023 | -2.46 |
| Dec 31, 2022 | -6.17 |
| Sep 30, 2022 | -3.52 |
| Jun 30, 2022 | -4.03 |
| Mar 31, 2022 | -3.00 |
| Dec 31, 2021 | -2.27 |
| Sep 30, 2021 | -4.42 |
| Jun 30, 2021 | -0.07 |
| Mar 31, 2021 | -4.16 |